Hasmukh Jain

India's recent approval of CAR T-Cell therapy for cancer is a game-changer. The potential of this treatment is enormous, with major pharma companies investing in their own projects. But challenges like efficacy, costs, and neurotoxicity still exist. Join the discussion on the future of this life-saving therapy with industry experts on The Morning Brief podcast.